How to Overcome the Limitations of Current Insulin Administration With New non-invasive Delivery Systems

References

• Kennedy F . Recent developments in insulin delivery techniques. Current status and future potential. Drugs42 (2), 213–227 (1991).
   PubMed Web of Science ®Google Scholar
• Li X Guo S Zhu C et al. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials34 (37), 9678–9687 (2013).
   PubMed Web of Science ®Google Scholar
• Giovino C Ayensu I Tetteh J Boateng J . Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Int. J. Pharm.428 (1–2), 143–151 (2012).
   PubMed Web of Science ®Google Scholar
• Chono S Fukuchi R Seki T Morimoto K . Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. J. Control. Release137 (2), 104–109 (2009).
   PubMed Web of Science ®Google Scholar
• Hinchcliffe M Illum L . Intranasal insulin delivery and therapy. Adv. Drug Deliv. Rev.35 (2–3), 199–234 (1999).
   PubMed Web of Science ®Google Scholar
• Liu S Jin M-N Quan Y-S et al. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J. Control. Release161 (3), 933–941 (2012).
   PubMed Web of Science ®Google Scholar
• Soares S Costa A Sarmento B . Novel non-invasive methods of insulin delivery. Expert Opin. Drug Deliv.9 (12), 1539–1558 (2012).
   PubMed Web of Science ®Google Scholar
• Heinemann L . New ways of insulin delivery. Int. J. Clin. Pract.65, 31–46 (2011).
   PubMed Web of Science ®Google Scholar
• Rosenfeld L . Insulin: discovery and controversy. Clin. Chem.48 (12), 2270–2288 (2002).
   PubMed Web of Science ®Google Scholar
• Kruszynska Y Home P Hanning I Alberti K . Basal and 24–h C-peptide and insulin secretion rate in normal man. Diabetologia30 (1), 16–21 (1987).
   PubMed Web of Science ®Google Scholar
• Vajo Z Fawcett J Duckworth W . Recombinant DNA technology in the treatment of diabetes: insulin analogs. Endocr. Rev.22 (5), 706–717 (2001).
   PubMed Web of Science ®Google Scholar
• Gwinup G Elias A Vaziri N . A case for oral insulin therapy in the prevention of diabetic micro- and macroangiopathy. Int. J. Artif. Organs13 (7), 393–395 (1990).
   PubMed Web of Science ®Google Scholar
• Hanas R Ludvigsson J . Experience of pain from insulin injections and needle-phobia in young patients with IDDM. Pract. Diabetes Int.14 (4), 95–99 (1997).
   Google Scholar
• Nordestgaard B Agerholm-Larsen B Stender S . Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits. Diabetologia40 (5), 512–520 (1997).
   PubMed Web of Science ®Google Scholar
• Sonaje K Lin K Wey S et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials31 (26), 6849–6858 (2010).
   PubMed Web of Science ®Google Scholar
• Gordon Still J . Development of oral insulin: progress and current status. Diabetes Metabol. Res. Rev.18 (Suppl. 1), S29–S37 (2002).
   PubMedGoogle Scholar
• Hamman Jh Enslin Gm Kotze Af . Oral delivery of peptide drugs: barriers and developments. BioDrugs19 (3), 165–177 (2005).
   PubMed Web of Science ®Google Scholar
• Owens Dr Zinman B Bolli G . Alternative routes of insulin delivery. Diabetic Med.20 (11), 886–898 (2003).
   PubMed Web of Science ®Google Scholar
• Woitiski Cb Sarmento B Carvalho Ra Neufeld Rj Veiga F . Facilitated nanoscale delivery of insulin across intestinal membrane models. Int. J. Pharm.412 (1–2), 123–131 (2011).
   PubMed Web of Science ®Google Scholar
• Lane Me O'driscoll C M Corrigan Oi . Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model. J. Pharm. Pharmacol.57 (2), 169–175 (2005).
   PubMed Web of Science ®Google Scholar
• Liu H Tang R Pan Ws Zhang Y Liu H . Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats. J. Pharm. Pharmacol.55 (11), 1523–1529 (2003).
   PubMed Web of Science ®Google Scholar
• Asada H Douen T Waki M et al. Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine. J. Pharm. Sci.84 (6), 682–687 (1995).
   PubMed Web of Science ®Google Scholar
• Morishita M Goto T Nakamura K Lowman Am Takayama K Peppas Na . Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. J. Control. Release110 (3), 587–594 (2006).
   PubMed Web of Science ®Google Scholar
• Katayama K Kato Y Onishi H Nagai T Machida Y . Double liposomes: hypoglycemic effects of liposomal insulin on normal rats. Drug Dev. Ind. Pharm.29 (7), 725–731 (2003).
   PubMed Web of Science ®Google Scholar
• Luzio Sd Dunseath G Lockett A Broke-Smith Tp New Rr Owens Dr . The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes. Diabetes Obes. Metabol.12 (1), 82–87 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang X Qi J Lu Y He W Li X Wu W . Biotinylated liposomes as potential carriers for the oral delivery of insulin. NanoMed.10 (1), 167–176 (2014).
   PubMed Web of Science ®Google Scholar
• Sudhakar Y Kuotsu K Bandyopadhyay AK . Buccal bioadhesive drug delivery–promising option for orally less efficient drugs. J. Control. Release114 (1), 15–40 (2006).
   PubMed Web of Science ®Google Scholar
• Park K Kwon Ic Park K . Oral protein delivery: current status and future prospect. React. Funct. Polym.71 (3), 280–287 (2011).
   Web of Science ®Google Scholar
• Heinemann L Jacques Y . Oral insulin and buccal insulin: a critical reappraisal. J. Diabetes Sci. Technol.3 (3), 568–584 (2009).
   PubMedGoogle Scholar
• Giovino C Ayensu I Tetteh J Boateng Js . An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles. Colloids Surf. B Biointerfaces112, 9–15 (2013).
   PubMed Web of Science ®Google Scholar
• Courrier Hm Butz N Vandamme Tf . Pulmonary drug delivery systems: recent developments and prospects. Crit. Rev. Ther. Drug Carrier Syst.19 (4–5), 425–498 (2002).
   PubMed Web of Science ®Google Scholar
• Hamishehkar H Emami J Najafabadi Ar et al. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin. Int. J. Pharm.389 (1–2), 74–85 (2010).
   PubMed Web of Science ®Google Scholar
• Balducci Ag Cagnani S Sonvico F et al. Pure insulin highly respirable powders for inhalation. Eur. J. Pharm. Sci.51 (0), 110–117 (2014).
   PubMedGoogle Scholar
• Hara K Tsujimoto H Tsukada Y Huang Cc Kawashima Y Tsutsumi M . Histological examination of PLGA nanospheres for intratracheal drug administration. Int. J. Pharm.356 (1–2), 267–273 (2008).
   PubMedGoogle Scholar
• Klingler C Muller Bw Steckel H . Insulin-micro- and nanoparticles for pulmonary delivery. Int. J. Pharm.377 (1–2), 173–179 (2009).
   PubMed Web of Science ®Google Scholar
• Usmani OS Biddiscombe MF Barnes PJ . Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am. J. Respir. Crit. Care Med.172 (12), 1497–1504 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Qadi S Grenha A Carrion-Recio D Seijo B Remunan-Lopez C . Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J. Control. Release157 (3), 383–390 (2012).
   PubMed Web of Science ®Google Scholar
• Liu J Gong T Fu H et al. Solid lipid nanoparticles for pulmonary delivery of insulin. Int. J. Pharm.356 (1–2), 333–344 (2008).
   PubMed Web of Science ®Google Scholar
• Khafagy El S Morishita M Isowa K Imai J Takayama K . Effect of cell-penetrating peptides on the nasal absorption of insulin. J. Control. Release133 (2), 103–108 (2009).
   PubMed Web of Science ®Google Scholar
• Leary Ac Dowling M Cussen K O'brien J Stote Rm . Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin) administered to healthy male volunteers: infuence of the nasal cycle. J. Diabetes Sci. Technol.2 (6), 1054–1060 (2008).
   PubMedGoogle Scholar
• Davis Ss Illum L . Absorption enhancers for nasal drug delivery. Clin. Pharmacokinet.42 (13), 1107–1128 (2003).
   PubMed Web of Science ®Google Scholar
• Ranaldi G Marigliano I Vespignani I Perozzi G Sambuy Y . The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1). J. Nutr. bioChem.13 (3), 157–167 (2002).
   PubMed Web of Science ®Google Scholar
• Natsume H Iwata S Ohtake K et al. Screening of cationic compounds as an absorption enhancer for nasal drug delivery. Int. J. Pharm.185 (1), 1–12 (1999).
   PubMedGoogle Scholar
• Khafagy El S Kamei N Nielsen Ej Nishio R Takeda-Morishita M . One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats. Eur. J. Pharm. bioPharm.85 (3 Pt A), 736–743 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang X Zhang X Wu Z et al. β-Cyclodextrin grafting hyperbranched polyglycerols as carriers for nasal insulin delivery. Carbohydrate Polymers84 (4), 1419–1425 (2011).
   Web of Science ®Google Scholar
• Prausnitz Mr Mitragotri S Langer R . Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov.3 (2), 115–124 (2004).
   PubMed Web of Science ®Google Scholar
• Thomas Bj Finnin Bc . The transdermal revolution. Drug Discov. Today9 (16), 697–703 (2004).
   PubMed Web of Science ®Google Scholar
• Foldvari M . Non-invasive administration of drugs through the skin: challenges in delivery system design. Pharm. Sci. Technol. Today3 (12), 417–425 (2000).
   PubMedGoogle Scholar
• Purdon Ch Azzi Cg Zhang J Smith Ew Maibach Hi . Penetration enhancement of transdermal delivery–current permutations and limitations. Crit. Rev. Ther. Drug Carrier Syst.21 (2), 97–132 (2004).
   PubMed Web of Science ®Google Scholar
• Khafagy El S Morishita M Onuki Y Takayama K . Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliv. Rev.59 (15), 1521–1546 (2007).
   PubMed Web of Science ®Google Scholar
• Bariya Sh Gohel Mc Mehta Ta Sharma Op . Microneedles: an emerging transdermal drug delivery system. J. Pharm. Pharmacol.64 (1), 11–29 (2012).
   PubMed Web of Science ®Google Scholar